1.
Am J Trop Med Hyg
; 105(5): 1134-1135, 2021 09 22.
Article
in English
| MEDLINE | ID: covidwho-1436185
Subject(s)
COVID-19/parasitology , Coinfection/diagnosis , Strongyloides stercoralis/isolation & purification , Strongyloidiasis/diagnosis , Adrenal Cortex Hormones/therapeutic use , Animals , COVID-19/diagnosis , COVID-19/therapy , Coinfection/parasitology , Coinfection/virology , Feces/parasitology , Humans , Larva , Male , Middle Aged , Serologic Tests , Strongyloidiasis/drug therapy , Strongyloidiasis/virology
2.
Am J Trop Med Hyg
; 103(4): 1590-1592, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-914663
ABSTRACT
The SARS-CoV-2 virus has emerged and rapidly evolved into a current global pandemic. Although bacterial and fungal coinfections have been associated with COVID-19, little is known about parasitic infection. We report a case of a COVID-19 patient who developed disseminated strongyloidiasis following treatment with high-dose corticosteroids and tocilizumab. Screening for Strongyloides infection should be pursued in individuals with COVID-19 who originate from endemic regions before initiating immunosuppressive therapy.